WebFind real-time CRIS - Curis Inc stock quotes, company profile, news and forecasts from CNN Business. Web21 hours ago · Curis (CRIS) (Real Time Quote from BATS) $0.92 USD +0.09 (10.44%) Updated Apr 13, 2024 01:57 PM ET Add to portfolio Zacks Rank: 2-Buy 2 Style Scores: C Value D Growth F Momentum D VGM...
Curis Reports Inducement Grants Under NASDAQ Listing Rule …
WebCuris, Inc. (CUSA) Stock Price & News - Google Finance Home CUSA • FRA Curis, Inc. Follow Share €0.50 Mar 31, 11:00:12 PM GMT+2 · EUR · FRA · Disclaimer search Compare to Cenovus Energy Inc... WebSep 8, 2024 · Curis' shares appeared to be a direct beneficiary of Pfizer's (PFE 1.59%) buyout of Trillium Therapeutics , another small-cap cancer company with an early-stage pipeline. inteso netherlands
Curis Inc (CRIS) Stock Price Today, News, Quotes, FAQs …
WebJun 11, 2024 · Cancer drug specialist Curis (CRIS 8.40%) had a Friday to forget. The biotech's share price took a nearly 37% hit after the company reported some disquieting news about a leading pipeline drug. WebCuris Inc. (NASDAQ:CRIS) has a beta value of 2.70 and has seen 4.46 million shares traded in the last trading session. The company, currently valued at $54.22M, closed the last trade at $0.56 per share which meant it lost -$0.09 on the day or -14.54% during that session. The CRIS stock price is -841.07% off …. WebCuris – Emavusertib (IRAK4i) At Curis, we are developing differentiated therapeutics with the goal of improving the lives of cancer patients. Our new animation shows how … Erivedge ® is the first FDA approved medicine for the treatment of metastatic … * IP licensed from Aurigene** Exclusive option to license IP from ImmuNext *** … We are seeking dedicated, driven, humble, hands-on professionals, from diverse … We are a biotechnology company focused on the development of first-in-class and … First-in-Class Suppressor of the TLR Pathway (Oral, Small Molecule IRAK4 … Management - Home - Curis, Inc Curis is conducting clinical trials to evaluate the efficacy and safety of potential … Board of Directors - Home - Curis, Inc new heart vs old heart